search again

Prostate Cancer Antibody Response Score

Nationwide rates for HCPCS 0021U

Assesses the likelihood of prostate cancer by measuring the immune system's antibody response to eight tumor-associated proteins, including ARF6, NKX3-1, BMI1, CEP164, Ropporin, desmocollin, AURKAIP-1 and CSNK2A2. The eight results are combined into a single risk score, and no genetic material is examined.

Rates data updated June 2026.

Facilitymedian $1,175 · 10th–90th $617$3,4670%20%10th90th$1,175Professionalmedian $603 · 10th–90th $417$9120%20%40%10th90th$603$0.0$0.2$2.0$20.0$200.0$2.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$645.65
Median
$1,318.26
Typical High
$3,467.37
Aetna
Setting
Professional
Modifier
Global
Typical Low
$501.19
Median
$602.56
Typical High
$870.96
BCBS
Setting
Facility
Modifier
Global
Typical Low
$645.65
Median
$1,202.26
Typical High
$3,630.78
BCBS
Setting
Professional
Modifier
Global
Typical Low
$199.53
Median
$302.00
Typical High
$812.83
Cigna
Setting
Facility
Modifier
Global
Typical Low
$524.81
Median
$1,445.44
Typical High
$3,311.31
Cigna
Setting
Professional
Modifier
Global
Typical Low
$870.96
Median
$1,122.02
Typical High
$1,819.70
United
Setting
Facility
Modifier
Global
Typical Low
$316.23
Median
$758.58
Typical High
$912.01
United
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$870.96